Medication adherence and persistence in hypertension management

Journal of Clinical Outcomes Management

Volumn 18, Issue 8, 2011, Pages 351-358

  Klootwyk, Jacqueline M ^a   Sanoski, Cynthia A ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROCHLOROTHIAZIDE; HYDROCHLOROTHIAZIDE PLUS VALSARTAN; VALSARTAN;

AFRICAN AMERICAN; AGE; ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE REGULATION; CAUCASIAN; COMBINATION CHEMOTHERAPY; DISEASE SEVERITY; DOCTOR PATIENT RELATION; DRUG COST; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG USE; GENDER; HEALTH CARE PERSONNEL; HUMAN; HYPERTENSION; PATIENT COMPLIANCE; PATIENT EDUCATION; PILL; PRESCRIPTION; RACE; REVIEW; SEX DIFFERENCE; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

EID: 80052245099     PISSN: 10796533     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (53)

1. Ostchega Y., Yoon S.S., Hughes J., et al. Hypertension awareness, treatment, and control-continued disparities in adults:United States, 2005-2006. NCHS Data Brief 2008;3:1-8.
2. Chobanian A.V., Bakris G.L., Black H.R., et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003;42:1206-1252 (Pubitemid 37553153)
3. Burnier M. Medication adherence and persistence as the cornerstone of effective antihypertensive therapy. Am J Hypertens 2006;19:1190-1196 (Pubitemid 44633590)
4. Wetzels G.E., Nelemans P., Schouten J.S., Prins M.H. Facts and fiction of poor compliance as a cause of inadequate blood pressure control:A systematic review. J Hypertens 2004;22:1849-1855 (Pubitemid 39336663)
5. Perreault S., Lamarre D., Blais L., et al. Persistence with treatment in newly treated middle-aged patients with essential hypertension. Ann Pharmacother 2005;39:1401-1408 (Pubitemid 41197117)
6. Bourgalt C., Senecal M., Brisson M., et al. Persistence and discontinuation patterns of antihypertensive therapy among newly treated patients:A population-based study. J Hum Hypertens 2005;19:607-613 (Pubitemid 41131661)
7. Caro J.J., Salas M., Speckman J.L., et al. Persistence with treatment for hypertension in actual practice. CMAJ 1999;160:31-37 (Pubitemid 29054224)
8. Bramley T.J., Gervino P.P., Nightengale B.S., Frech-Tamas F. Relationship of blood pressure control to adherence with antihypertensive monotherapy in 13 managed care organizations. J Manag Care Pharm 2006;12:239-245 (Pubitemid 47400613)
9. Mazzaglia G., Ambrosioni E., Alacqua M., et al. Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients. Circulation 2009;120:1598-1605
10. Dragomir A., Côté R., Roy R., et al. Impact of adherence to antihypertensive agents on clinical outcomes and hospitalization costs. Med Care 2010;48:418-425
11. Sokol M.C., McGuigan K.A., Verbrugge R.R., Epstein R.S. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care 2005;43:521-530 (Pubitemid 40847288)
12. Wu P.H., Yang C.Y., Yao Z.L., et al. Relationship of blood pressure control and hospitalization risk to medication adherence among patients with hypertension in Taiwan. Am J Hypertens 2010;23:155-160
13. Di Martino M., Veronesi C., Degli Esposti L., et al. Adherence to antihypertensive drug treatment and blood pressure control:A real practice analysis in Italy. J Hum Hypertens 2008;22:51-53 (Pubitemid 350269256)
14. Krousel-Wood M.A., Muntner P., Islam T., et al. Barriers to and determinants of medications adherence in hypertension management:Perspective of the cohort study of medication adherence among older adults. Med Clin North Am 2009;93:753-769
15. Shaya F.T., Du D., Gbarayor C.M., et al. Predictors of compliance with antihypertensive therapy in a high-risk medicaid population. J Natl Med Assoc 2009;101:34-39
16. Shah N.R., Hirsch A.G., Zacker C., et al. Predictors of first-fill adherence for patients with hypertension. Am J Hypertens 2009;22:392-396
17. Bautista L.E. Predictors of persistence with antihypertensive therapy:Results from the NHANES. Am J Hypertens 2008;21:183-188 (Pubitemid 351231565)
18. Wilson J., Axelsen K., Tang S. Medicaid prescription drug access restrictions:Exploring the effect on patient persistence with hypertension medications. Am J Manag Care 2005;11 Spec No:SP27-SP34
19. Van Wijk B.L.G., Klungel O.H., Heerdink E.R., De Boer A. The association between compliance with antihypertensive drugs and modification of antihypertensive drug regimen. J Hypertens 2004;22:1831-1837 (Pubitemid 39141977)
20. Bosworth H.B., Dudley T., Olsen M.K., et al. Racial differences in blood pressure control:Potential explanatory factors. Am J Med 2006;119:e9-15.
21. Sudano J.J., Baker D.W. Antihypertensive medication use in Hispanic adults:A comparison with black adults and white adults. Med Care 2001;39:575-587 (Pubitemid 33603643)
22. Benner J.S., Chapman R.H., Petrilla A.A., et al. Association between prescription burden and medication adherence in patients initiating antihypertensive and lipid-lowering therapy. Am J Health-Syst Pharm 2009;66:1471-1477
23. Chapman R.H., Petrilla A.A., Benner J.S., et al. Predictors of adherence to concomitant antihypertensive and lipid-lowering medications in older adults:A retrospective, cohort study. Drugs Aging 2008;25:855-892
24. Jackson K.C., Sheng X., Nelson R.E., et al. Adherence with multiple-combination antihypertensive pharmacotherapies in a US managed care database. Clin Ther 2008;30:1558-1563
25. Brixner D.I., Jackson K.C., Sheng X., et al. Assessment of adherence, persistence, and costs among valsartan and hydrochlorothiazide retrospective cohorts in free-and fixed-dose combinations. Curr Med Res Opin 2008;24:2597-2607
26. Vawter L., Tong X., Gemilyan M., Yoon P.W. Barriers to antihypertensive medication adherence among adults - United States, 2005. J Clin Hypertens (Greenwich) 2008;10:922-929
27. Parati G., Bilo G. Practical aspects of treatment discontinuation and adherence. J Hypertens 2009;27(Suppl 2): S18-S21
28. Düsing R., Weisser B., Mengden T., Vetter H. Changes in antihypertensive therapy:The role of adverse effects and compliance. Blood Press 1998;7:313-315 (Pubitemid 29182821)
29. Andrade J.P., Vilas-Boas F., Chagas H., Andrade M. Epidemiological aspects of adherence to the treatment of hypertension. Arq Bras Cardiol 2002;79:375-384
30. Lachaine J., Petrella R.J., Merikle E., Ali F. Choices, persistence and adherence to antihypertensive agents:Evidence from RAMQ data. Can J Cardiol 2008;24:269-273 (Pubitemid 351771460)
31. Patel B.V., Remigio-Baker R.A., Mehta D., et al. Effects of initial antihypertensive drug class on patient persistence and compliance in a usual-care setting in the United States. J Clin Hypertens (Greenwich) 2007;9:692-700.
32. Goldman D.P., Joyce G.F., Escarce J.J., et al. Pharmacy benefits and the use of drugs by the chronically ill. JAMA 2004;291:2344-2350 (Pubitemid 38656301)
33. Briesacher B.A., Andrade S.E., Fouazyi H., Chan K.A. Medication adherence and use of generic drug therapies. Am J Manag Care 2009;15:450-456
34. Briesacher B.A., Limcangco M.R., Frech-Tamas F. New-user persistence with antihypertensives and prescription drug cost-sharing. J Clin Hypertens 2007;9:831-836
35. Bloom B.S. Continuation of initial antihypertensive medication after 1 year of therapy. Clin Ther 1998;20:671-681 (Pubitemid 28421488)
36. Agarwal S., Tang S.S., Rosenberg N., et al. Does synchronizing initiation of therapy affect adherence to concomitant use of antihypertensive and lipid-lowering therapy? Am J Ther 2009;16:119-126
37. Hill M.N., Miller N.H., DeGeest S. ASH Position Paper:Adherence and persistence with taking medication to control high blood pressure. J Clin Hypertens 2010;12:757-764
38. Robinson J.D., Segal R., Lopez L.M., Doty R.E. Impact of a pharmaceutical care intervention on blood pressure control in a chain pharmacy practice. Ann Pharmacother 2010;44:88-96.
39. Green B.B., Cook A.J., Balston J.D., et al. Effectiveness of home blood pressure monitoring, Web communication, and pharmacist care on hypertension control:A randomized controlled trial. JAMA 2008;299:2857-2867 (Pubitemid 351930885)
40. Lee J.K., Grace K.A., Taylor A.J. Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol:A randomized controlled trial. JAMA 2006;296:2563-2571 (Pubitemid 44903860)
41. Planas L.G., Crosby K.M., Mitchell K.D., Farmer K.C. Evaluation of a hypertension medication therapy management program in patients with diabetes. J Am Pharm Assoc 2009;49:164-170
42. Carter B.L., Ardery G., Dawson J.D., et al. Physician and pharmacist collaboration to improve blood pressure control. Arch Intern Med 2009;169:1996-2002.
43. Morgado M., Rolo S., Castelo-Branco M. Pharmacist intervention program to enhance hypertension control:A randomised controlled trial. Int J Clin Pharm 2011;33:132-140
44. Morisky D.E., Green L.W., Levine D.M. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986;24:67-74. (Pubitemid 16125389)
45. Karagiannis A., Hatzitolios A.I., Athyros V.G., et al. Implementation of guidelines for the management of arterial hypertension:The impulsion study. Open Cardiovasc Med J 2009;3:26-34.
46. Fongwa M.N., Evangelista L.S., Hays R.D., et al. Adherence treatment factors in hypertensive African American women. Vasc Health Risk Manag 2008;4:157-166 (Pubitemid 351460856)
47. Gascon J.J., Sanchez-Ortuno M., Llor B., et al. Why hypertensive patients do not comply with the treatment:Results from a qualitative study. Fam Pract 2004;21:125-130 (Pubitemid 38489390)
48. Turner B.J., Hollenbeak C., Weiner M.G., et al. Barriers to adherence and hypertension control in a racially diverse representative sample of elderly primary care patients. Pharmacoepidemiol Drug Saf 2009;18:672-681
49. Schoenthaler A., Chaplin W.F., Allegrante J.P., et al. Provider communication effects medication adherence in hypertensive African Americans. Patient Educ Couns 2009;75:185-191
50. Roumie C.L., Greevy R., Wallston K.A., et al. Patient centered primary care is associated with patient hypertension medication adherence. J Behav Med 2010 Dec 16.
51. Safran D.G., Kosinski M., Tarlov A R, et al. The primary care assessment survey:Tests of data quality and measurement performance. Med Care 1998;36:728-739. (Pubitemid 128456428)
52. Alhalaiqa F., Deane K.H.O., Nawafleh A.H., et al. Adherence therapy for medication non-compliant patients with hypertension: a randomised controlled trial. J Hum Hypertens 17 February 2011.
53. Ogedeghe G., Chaplin W., Schoenthaler A., et al. A practice- based trial of motivational interviewing and adherence in hypertensive African Americans. Am J Hypertens 2008;21:1137-1143